X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9538) 9538
Book Review (2104) 2104
Publication (1027) 1027
Book Chapter (103) 103
Conference Proceeding (85) 85
Dissertation (16) 16
Newspaper Article (6) 6
Web Resource (4) 4
Government Document (3) 3
Magazine Article (3) 3
Streaming Video (3) 3
Trade Publication Article (2) 2
Book / eBook (1) 1
Data Set (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7383) 7383
humans (5533) 5533
immunology (3479) 3479
animals (3420) 3420
ctla-4 (3280) 3280
ctla-4 antigen (3031) 3031
female (2511) 2511
immunotherapy (2374) 2374
mice (2358) 2358
male (2186) 2186
oncology (1977) 1977
antigens, cd (1683) 1683
cancer (1648) 1648
abatacept (1511) 1511
t cells (1448) 1448
ctla-4 protein (1362) 1362
expression (1358) 1358
immunoconjugates (1324) 1324
melanoma (1324) 1324
lymphocytes (1277) 1277
t-lymphocytes - immunology (1277) 1277
middle aged (1261) 1261
adult (1250) 1250
ipilimumab (1196) 1196
lymphocytes t (1017) 1017
ctla-4 blockade (1011) 1011
activation (1008) 1008
abridged index medicus (997) 997
cd28 (946) 946
antibodies, monoclonal - therapeutic use (907) 907
antigens (900) 900
ctla-4 antigen - immunology (878) 878
dendritic cells (842) 842
aged (836) 836
metastatic melanoma (830) 830
lymphocyte activation (828) 828
pd-1 (824) 824
antigens, differentiation - genetics (815) 815
t-cells (794) 794
mice, inbred c57bl (786) 786
t-lymphocytes, regulatory - immunology (768) 768
research (741) 741
tumors (741) 741
ctla-4 antigen - antagonists & inhibitors (736) 736
medicine, research & experimental (733) 733
care and treatment (727) 727
in-vivo (710) 710
antigens, differentiation - immunology (707) 707
autoimmunity (705) 705
regulatory t-cells (664) 664
antigens, cd - immunology (662) 662
mice, inbred balb c (661) 661
analysis (639) 639
immunotherapy - methods (639) 639
flow cytometry (628) 628
cytotoxicity (625) 625
ctla-4 antigen - genetics (619) 619
chemical and pharmacologic phenomena (618) 618
genetic aspects (617) 617
cd4-positive t-lymphocytes - immunology (606) 606
article (605) 605
genetic predisposition to disease (604) 604
immune checkpoint (594) 594
cell biology (572) 572
transplantation (569) 569
antigens, cd - genetics (568) 568
cells, cultured (564) 564
neoplasms - immunology (564) 564
gene expression (548) 548
apoptosis (542) 542
susceptibility (537) 537
immune response (536) 536
melanoma - drug therapy (535) 535
blockade (532) 532
genotype (528) 528
costimulation (526) 526
antigen (512) 512
patients (509) 509
ctla-4 antigen - metabolism (508) 508
cytokines (506) 506
receptor (503) 503
disease (501) 501
induction (493) 493
nivolumab (492) 492
health aspects (490) 490
programmed cell death 1 receptor - antagonists & inhibitors (482) 482
therapy (479) 479
antigens, cd - metabolism (475) 475
tolerance (475) 475
biochemistry & molecular biology (459) 459
antibodies (456) 456
antigens, differentiation - metabolism (456) 456
lymphocyte activation - immunology (454) 454
immune system (453) 453
responses (453) 453
antineoplastic agents - therapeutic use (449) 449
t cell receptors (444) 444
case-control studies (443) 443
multidisciplinary sciences (440) 440
b7-2 antigen (438) 438
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9214) 9214
Chinese (108) 108
French (77) 77
Japanese (69) 69
German (66) 66
Polish (27) 27
Spanish (22) 22
Russian (13) 13
Czech (12) 12
Korean (12) 12
Portuguese (6) 6
Hungarian (5) 5
Turkish (5) 5
Danish (3) 3
Persian (3) 3
Swedish (3) 3
Dutch (2) 2
Finnish (2) 2
Hebrew (1) 1
Italian (1) 1
Norwegian (1) 1
Romanian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 2, pp. 122 - 133
Journal Article
Nature, ISSN 0028-0836, 11/2017, Volume 551, Issue 7681, pp. 517 - 520
Checkpoint blockade immunotherapies enable the host immune system to recognize and destroy tumour cells(1). Their clinical activity has been correlated with... 
CELL LUNG-CANCER | CTLA-4 BLOCKADE | MELANOMA | THERAPY | LANDSCAPE | PD-1 BLOCKADE | MULTIDISCIPLINARY SCIENCES | SENSITIVITY | RESISTANCE | CLINICAL-RESPONSE | REPERTOIRES | Humans | Lung Neoplasms - pathology | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antigen Presentation | Melanoma - genetics | Immunotherapy | Cell Cycle Checkpoints - genetics | Cell Cycle Checkpoints - immunology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Antigens, Neoplasm - genetics | Antigens, Neoplasm - immunology | Carcinoma, Non-Small-Cell Lung - genetics | Lymphocyte Activation | CTLA-4 Antigen - genetics | Lung Neoplasms - therapy | Melanoma - pathology | CTLA-4 Antigen - immunology | Carcinoma, Non-Small-Cell Lung - immunology | Carcinoma, Non-Small-Cell Lung - therapy | Lung Neoplasms - immunology | Models, Immunological | Melanoma - immunology | Survival Analysis | T-Lymphocytes - immunology | Programmed Cell Death 1 Receptor - immunology | CTLA-4 Antigen - antagonists & inhibitors | Melanoma - therapy | Programmed Cell Death 1 Receptor - genetics | Cohort Studies | Evolution, Molecular | Antigens | Care and treatment | Patient outcomes | Models | Health aspects | Tumors | Medical research | Peptides | PD-1 protein | Lung cancer | Melanoma | Cytotoxicity | Lymphocytes T | Patients | Proteins | Cell recognition | CTLA-4 protein | Major histocompatibility complex | Immune checkpoint | Lymphocytes | Evolution | Mutation | Histocompatibility | Cancer | Immune system | Fitness | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2015, Volume 112, Issue 2, pp. 524 - 529
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, pp. e53745 - e53745
Background: Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces... 
TRIAL | CTLA-4 BLOCKADE | INDUCED SARCOIDOSIS | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | AUTOIMMUNE-DISEASES | PHASE-I/II | MULTIDISCIPLINARY SCIENCES | TREMELIMUMAB CP-675,206 | MONOCLONAL-ANTIBODY | PATIENT | CANCER | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Neoplasm Metastasis | Liver - drug effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Endocrine System - drug effects | Adult | Female | Retrospective Studies | Antibodies, Monoclonal - immunology | Kidney - drug effects | Antineoplastic Agents - immunology | Pancreas - drug effects | Gastrointestinal Tract - drug effects | Melanoma - pathology | CTLA-4 Antigen - immunology | Nervous System - drug effects | Melanoma - drug therapy | Respiratory System - drug effects | Aged | Skin - drug effects | Antimitotic agents | Antigens | Care and treatment | Algorithms | Lymphocytes | Melanoma | Skin | Metastasis | Antineoplastic agents | Skin cancer | Cancer | Aseptic meningitis | Guillain-Barre syndrome | Exanthema | Central nervous system | Blocking antibodies | Cytotoxicity | Oncology | Lymphocytes T | Metastases | CTLA-4 protein | Intestine | Gastroenterology | Meningitis | Internal medicine | Hematology | Sarcoidosis | Dermatology | Management | Regression analysis | Patients | Eosinophilia | Morbidity | Inflammatory bowel disease | Pathology | Side effects | Hospitals | Perforations | Medical prognosis | Antitumor activity | Autoimmune diseases | Endocrinology | Index Medicus
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2014, Volume 371, Issue 23, pp. 2189 - 2199
Journal Article
Blood, ISSN 0006-4971, 02/2019, Volume 133, Issue 7, pp. 629 - 630
In this issue of Blood, Zhao et al explored the role of low doses of the histone deacetylase inhibitor (HDACi) chidamide in restoring immune tolerance in... 
HEMATOLOGY | IMMUNE THROMBOCYTOPENIA | CTLA-4
Journal Article